ClinConnect ClinConnect Logo
Search / Trial NCT06571162

A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients

Launched by INTERMOUNTAIN HEALTH CARE, INC. · Aug 22, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how a team of clinical pharmacists can help manage cholesterol levels, specifically LDL cholesterol (often referred to as "bad" cholesterol), in patients who have had a heart or blood vessel-related event, known as atherosclerotic cardiovascular disease (ASCVD). The goal is to see if patients who receive special care from pharmacists are more likely to reach recommended cholesterol levels of less than 70 mg/dL. Participants will be randomly assigned to either receive this pharmacist-led care or not, and they can choose to stop participating in the cholesterol management program at any time.

To be eligible for this trial, you need to be over 18 years old, receive care from Intermountain Health, and have a documented history of ASCVD. This could include conditions like heart disease or strokes. If you decide to join, you will be followed for one year to track how well the program works. This trial is not yet recruiting, so there’s no immediate action needed, but it’s an important step in finding better ways to manage cholesterol and improve heart health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Male or female \>18 years of age
  • 2. Receive follow-up care with Intermountain Health
  • 3. Value-based patient (as defined in the EDW)
  • 4. Documentation of an ASCVD diagnosis, by 1 of the following:
  • Coronary artery disease (Primary inpatient CAD diagnosis during index encounter; Primary inpatient MI diagnosis during index encounter; PCI during index encounter; or CABG during index encounter
  • Cerebrovascular accident (Primary inpatient ischemic stroke diagnosis during index encounter; Carotid endarterectomy during index encounter; or Carotid stent during index encounter)
  • Peripheral arterial disease (Bypass or percutaneous intervention during index encounter)
  • Exclusion Criteria:
  • 1. Patient age \<18 years.
  • 2. Receipt of or expected receipt of palliative care, expected discharge to hospice, or long-term care facility (i.e., skilled nursing facility).
  • 3. Pregnant or lactating women

About Intermountain Health Care, Inc.

Intermountain Health Care, Inc. is a leading nonprofit healthcare system based in Salt Lake City, Utah, dedicated to improving community health through innovative clinical practices and rigorous research initiatives. With a commitment to evidence-based care and patient-centered approaches, Intermountain actively sponsors clinical trials that aim to advance medical knowledge and enhance treatment options across various health conditions. The organization leverages its extensive network of hospitals, outpatient facilities, and specialized care services to facilitate high-quality research while prioritizing patient safety and ethical standards. Through collaboration with healthcare professionals and academic institutions, Intermountain Health Care strives to contribute significantly to the advancement of healthcare practices and outcomes.

Locations

Salt Lake City, Utah, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported